ABOUT DESIGNED BIOLOGICS

Different disciplines.
A shared ambition.

At the intersection of molecular biology, artificial intelligence, and large-scale computing, we’re building new ways to solve complex biological challenges.

OTTAWA, CANADA

Precision at the molecular level.
Possibility at the human level.

Designed Biologics was founded by two researchers whose complementary expertise in molecular biology and computer science helped establish the foundation of our peptide discovery technology. Today, that foundation supports our own programs and the work of our partners.

OUR CO-FOUNDERS

Expertise that connects.

Professor Ashkan Golshani

CO-FOUNDER

Professor Ashkan Golshani

Molecular biology · Systems biology · Peptide discovery

Dr. Ashkan Golshani is a pioneer in AI-guided peptide design, a Full Professor and Director of the Systems Biology Group at Carleton University, and a Principal Investigator in the Faculty of Medicine at the University of Ottawa.

With over two decades of research in peptide engineering, his work integrates molecular genetics, artificial intelligence, and high-performance supercomputing. He has been a driving force in developing methods to map and manipulate protein–protein interactions (PPIs), a foundation for target-specific drug discovery.

Notably, in 2008, together with Dr. Dehne's group, he led a team that computationally predicted the first-ever protein interaction map of a cell. In early 2020, using Canada's most powerful supercomputers, his laboratory engineered synthetic peptides that reduced SARS-CoV-2 infection by 75% in laboratory testing.

Dr. Golshani has also made fundamental contributions to genomics, including characterizing and naming more than a dozen previously orphan genes. A frequent keynote and seminar speaker at international scientific and industry events, he is recognized for connecting basic research with clinical applications.

His current work continues to advance AI-guided platforms for discovering precision diagnostics and therapeutics that minimize toxicity while addressing complex human diseases.

View publications on PubMed
Professor Frank Dehne

CO-FOUNDER

Professor Frank Dehne

Data science · Artificial intelligence · High-performance computing

Dr. Dehne is Chancellor’s Professor (Emeritus) at Carleton University. His interdisciplinary research uses large-scale cloud systems and GPUs to address computationally demanding problems in bioinformatics, data analytics, and engineering.

He has served as Director of the School of Computer Science and Founding Director of the Institute for Data Science. His work helps bring the computational scale needed to explore complex biological questions.

His academic profile includes extensive peer-reviewed publications, research collaborations, editorial service, and recognition in the Stanford–Elsevier list of highly cited scientists.

View academic profile

THE NEXT DISCOVERY STARTS WITH A CONVERSATION

The right expertise. A shared goal.

Let’s explore what we can build together.

Let’s connect